Newbridge Financial Services Group, Inc. Gilead Sciences, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $262 Million
- Q2 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 4,165 shares of GILD stock, worth $344,945. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,165
Previous 1,703
144.57%
Holding current value
$344,945
Previous $124,000
129.84%
% of portfolio
0.11%
Previous 0.06%
Shares
16 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$9.99 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.55 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.32 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.91 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $104B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...